Am­gen, Janssen reach set­tle­ment on Ste­lara biosim­i­lar drug, al­low­ing for 2025 launch at lat­est

Am­gen and Janssen set­tled their law­suit over a biosim­i­lar op­tion to J&J’s block­buster bi­o­log­ic Ste­lara — paving the way for the new­er drug to en­ter the mar­ket.

Am­gen told End­points News in a state­ment that the terms of the set­tle­ment, which were an­nounced Mon­day via a court fil­ing, re­main con­fi­den­tial. How­ev­er, Am­gen will be al­lowed to launch its Ste­lara biosim­i­lar “no lat­er than Jan­u­ary 1st, 2025.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER